Neovacs S.A. (EPA:ALNEV)
1.180
-0.620 (-34.44%)
Jul 25, 2025, 5:35 PM CET
Neovacs Employees
Neovacs had 20 employees as of December 31, 2024. The number of employees decreased by 2 or -9.09% compared to the previous year.
Employees
20
Change (1Y)
-2
Growth (1Y)
-9.09%
Revenue / Employee
$21,697
Profits / Employee
-$1,645,720
Market Cap
471.86K
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 20 | -2 | -9.09% |
Dec 31, 2023 | 22 | 1 | 4.76% |
Dec 31, 2022 | 21 | 2 | 10.53% |
Dec 31, 2021 | 19 | 4 | 26.67% |
Dec 31, 2020 | 15 | -8 | -34.78% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
EssilorLuxottica Société anonyme | 153,498 |
Sanofi | 82,878 |
Sartorius Stedim Biotech | 9,901 |
bioMérieux | 14,754 |
Eurofins Scientific SE | 62,696 |
Ipsen | 5,358 |
ABIVAX Société Anonyme | 69 |
Virbac | 6,365 |